Hydroxychloroquine (Plaquenil) Dosing Calculator

ورودی‌های بالینی بیمار

حداقل ۲۰ — حداکثر ۳۰۰ • واحد: kg

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
max daily dose
—mg
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Low Dose0–200
  • Standard Dose201–400
  • High Dose401–600
Direct Clinical Answer

The Hydroxychloroquine (Plaquenil) Dosing Calculator calculates calculating maximum daily hydroxychloroquine dose to reduce retinopathy risk. Key inputs include weight kg. Scores guide initiating or optimizing disease-modifying antirheumatic drugs (DMARDs) or targeted biologic therapies. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Calculates maximum daily hydroxychloroquine dose to reduce retinopathy risk. Uses actual body weight to determine safe dosing limits based on 2016 American Academy of Ophthalmology guidelines recommending ≤5 mg/kg/day to minimize retinal toxicity.

Clinical Indication

The Hydroxychloroquine (Plaquenil) Dosing Calculator is indicated for bedside clinical practice to support Calculates maximum daily hydroxychloroquine dose to reduce retinopathy risk. Uses actual body weight to determine safe dosing limits based on 2016 American Academy of Ophthalmology guidelines recommending ≤5 mg/kg/day to minimize retinal toxicity.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with inflammatory arthritis, systemic lupus erythematosus, systemic vasculitis, or autoimmune connective tissue disorders. Clinical application is indicated across Rheumatology clinics, connective tissue disease units, and academic medical centers.

Limitations & Contraindications

Elevated erythrocyte sedimentation rate (ESR) and CRP are non-specific acute phase reactants that can reflect occult systemic infection.

Clinical Pearls & Action Plan

Serological autoantibody testing must strictly correlate with inflammatory joint patterns and objective synovial pathology. Guideline pearl: 2016 AAO guidelines reduced maximum dose from 6.5 mg/kg to 5 mg/kg based on retinopathy evidence.

Formula & Variables:

Maximum daily dose (mg) = actual body weight (kg) × 5 mg/kg. Consider dose reduction if risk factors present or for long-term use (>5 years).

Input Parameters

NameTypeRequiredDescription
weight_kgfloatYesPatient's actual body weight in kilograms(kg)
indicationstringYesClinical indication for hydroxychloroquine therapy
risk_factorsstringYesPresence of risk factors for retinopathy (age >65, renal disease, liver disease, previous retinal disease)

Score Interpretation & Guidance

RangeStageDescription
0–200Low Dose≤200 mg daily
201–400Standard Dose201-400 mg daily
401–600High Dose>400 mg daily

Evidence-Based References (EBM)

  • Marmor MF, Kellner U, Lai TY, Melles RB, Mieler WF. Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision). Ophthalmology. 2016 Jun;123(6):1386-94.
  • Melles RB, Marmor MF. The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy. JAMA Ophthalmol. 2014 Dec;132(12):1453-60.
  • Jorge AM, Melles RB, Zhang Y, Lu N, Rai SK, Young LH, Choi HK. Hydroxychloroquine retinopathy--implications of research advances for rheumatology care. Nat Rev Rheumatol. 2018 Dec;14(12):693-703.

Related calculators